| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Former 10% Owner
2 companies
Essetifin Spa serves as a 10% Owner at FENC and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 5 buys and 3 sells. Those positions are worth an estimated $25.5M at current prices.
The biggest single holding is FENC (~$25.0M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 1,062,115 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 30, 2020 | FENC Fennec Pharmaceuticals Inc. | 10% Owner | Buy | 768,000 | $6.25 | $4,800,000.00 | +23.8% | |
| Dec 12, 2017 | FENC Fennec Pharmaceuticals Inc. | 10% Owner | Buy | 294,115 | $8.50 | $2,499,977.50 | +10.0% | |
| Nov 29, 2017 | SNGX Soligenix, Inc. | Former 10% Owner | Buy | 293,510 | $2.12 | $622,241.20 | New | |
| Nov 29, 2017 | SNGX Soligenix, Inc. | Former 10% Owner | Sell | 293,510 | $2.12 | $622,241.20 | -100% |